Earnings Call
Jul 16, 2026
Q2 FY2026
EPS Estimate
4.87
EPS Actual
6.38
Post-Earnings Close
$423.38
Earnings Reaction
+1.2%
UnitedHealth Group's second quarter 2026 results mark a meaningful inflection in the company's recovery narrative, with adjusted EPS of $6.38, well ahead of the $4.87 consensus estimate and up 56% from $4.08 in Q2 2025. Total revenues came in at $112 billion, roughly flat year-over-year but consistent with expectations, while operating earnings of $8 billion surged 55% as the product and pricing actions taken over the past twelve months began to flow through in earnest. The reported medical care ratio of 86.7%, down from 89.4% a year ago, was aided by $860 million of net favorable prior period development, the majority of which was in-year. Management was direct in acknowledging this tailwind while arguing the underlying earnings quality is durable, a view supported by operating cash flows of approximately $11 billion, or 1.9 times net income.
Report generated on Jul 16, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full UNH analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.